Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis

Document Type : Research article

Authors

1 Department of Pharmaceutics, School of Pharmacy and Novel Drug Delivery Systems Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Department of Pharmacology, School of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.

10.22037/ijpr.2021.115481.15394

Abstract

In the present study, imatinib-loaded transfersomal gel (imatinib-TFS-Gel) was developed to minimize the oral dosing frequency and side effects during rheumatoid arthritis (RA) therapy. Imatinib-loaded transfersomes (imatinib-TFS) were prepared by the film-hydration method. The effects of lecithin content, lecithin/ EA ratio, and the type of EA on the characteristics of the imatinib-TFS were studied using a D-optimal design. Morphology of imatinib-TFS was investigated using scanning electron microscopy. The optimized imatinib-TFS formulation was used to prepare imatinib-TFS-Gel with the aid of Carbopol 940 as the gelling agent. The Optimized imatinib-TFS had a spherical shape with the particle size of 140.53 ± 0.87 nm, polydispersity index of 0.44 ± 0.01, the zeta potential of -17.63 ± 0.65 mV, encapsulation efficiency of 98.70 ± 0.38%, and release efficiency of 81.26 ± 0.70 %. Ex-vivo skin permeation studies through the rat skin showed that the cumulative amount of imatinib permeated from imatinib-TFS-Gel was significantly higher than that from imatinib-Gel. The RA rat model indicated a substantial reduction in paw edema during the 14 days study following the application of imatinib-TFS-Gel as compared with imatinib-Gel. Therefore, imatinib-TFS-Gel can be considered as a promising drug delivery system for the treatment of RA.

Graphical Abstract

Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis

Keywords


References
(1) Gai W, Hao X, Zhao J, Wang L, Liu J, Jiang H, Jin
H, Liu G and Feng Y. Delivery of benzoylaconitine
using biodegradable nanoparticles to suppress
inflammation via regulating NF-κB signaling.
Colloids Surf. B: Biointerfaces. (2020): 110980
(2) Salem HF, Nafady MM, Kharshoum RM, Abd
el-Ghafar OA and Farouk HO. Mitigation of
Rheumatic Arthritis in a Rat Model via Transdermal
Delivery of Dapoxetine HCl Amalgamated as a
Nanoplatform: In-vitro and in-vivo Assessment.
Int. J. Nanomedicine (2020) 15: 15-7.
(3) Eklund KK and Joensuu H. Treatment of rheumatoid
arthritis with imatinib mesylate: clinical
improvement in three refractory cases. Ann. Med.
(2003) 35: 362-7.
(4) Sandler C, Joutsiniemi S, Lindstedt KA, Juutilainen
T, Kovanen PT and Eklund KK. Imatinib mesylate
inhibits platelet derived growth factor stimulated
proliferation of rheumatoid synovial fibroblasts.
Biochem. Biophys. Res. Commun. (2006) 347: 31-
5.
(5) Paniagua RT and Robinson WH. Imatinib for the
treatment of rheumatic diseases. Clin. Pract.
Rheumatol. (2007) 3: 190-1.
(6) Kaur A, Goindi S and Katare OP. Formulation,
characterisation and in vivo evaluation of lipidbased
nanocarrier for topical delivery of diflunisal.
J. Microencapsul. (2016) 33: 475-86.
(7) Nagai N, Yoshioka C and Ito Y. Topical therapies for
rheumatoid arthritis by gel ointments containing
indomethacin nanoparticles in adjuvant-induced
arthritis rat. J. Oleo Sci. (2015) 64: 337-46.
(8) Malakar J, Sen SO, Nayak AK and Sen KK.
Formulation, optimization and evaluation of
transferosomal gel for transdermal insulin delivery.
Saudi Pharm J. (2012) 20: 355-63.
(9) Abdellatif MM, Khalil IA and Khalil MA.
Sertaconazole nitrate loaded nanovesicular systems
for targeting skin fungal infection: in-vitro, ex-vivo
and in-vivo evaluation. . Int. J. Pharm. (2017) 527:
1-10.
(10) Dudhipala N, Phasha Mohammed R, Adel Ali
Youssef A and Banala N. Effect of lipid and
edge activator concentration on development
of aceclofenac-loaded transfersomes gel for
transdermal application: in-vitro and ex-vivo skin
permeation. Drug Dev. Ind. Pharm. (2020) 46:
1334-44.
(11) Cevc G, Schätzlein A and Richardsen H.
Ultradeformable lipid vesicles can penetrate the skin
and other semi-permeable barriers unfragmented.
Evidence from double label CLSM experiments
and direct size measurements. Biochim. Biophys.
Acta (2002) 1564: 21-30.
(12) Benson HA. Transfersomes for transdermal drug
delivery. Expert. Opin Drug Deliv. (2006) 3: 727-
37.
(13) Nasr S, Varshosaz J and Hajhashemi V. Orthovanillin
nanoparticle-doped glucan microspheres
exacerbate the anti-arthritic effects of methotrexate
in adjuvant-induced arthritis in rats. Pharmacol
Rep. (2020) 72: 680-91.
(14) Qushawy M, Nasr A, Abd-Alhaseeb M and Swidan
S. Design, optimization and characterization
of a transfersomal gel using miconazole nitrate
for the treatment of candida skin infections.
Pharmaceutics (2018) 10: 26.
(15) Salama HA, Mahmoud AA, Kamel AO, Abdel Hady
M and Awad GA. Brain delivery of olanzapine by
intranasal administration of transfersomal vesicles.
46
Taymouri S et al. / IJPR (2021), 20 (4): 33-46
J. Liposome Res. (2012) 22: 336-45.
(16) Aboud HM, Ali AA, El-Menshawe SF and Elbary
AA. Nanotransfersomes of carvedilol for intranasal
delivery: formulation, characterization and in-vivo
evaluation. Drug deliv. (2016) 23: 2471-81.
(17) Liu D, Hu H, Lin Z, Chen D, Zhu Y, Hou S and Shi
X. Quercetin deformable liposome: preparation and
efficacy against ultraviolet B induced skin damages
in-vitro and in-vivo. J. Photochem. Photobiol. B.
(2013) 127: 8-17.
(18) Khan MA, Pandit J, Sultana Y, Sultana S, Ali A,
Aqil M and Chauhan M. Novel carbopol-based
transfersomal gel of 5-fluorouracil for skin cancer
treatment: in-vitro characterization and in-vivo
study. Drug Deliv. (2015) 22: 795-802.
(19) Avadi MR, Sadeghi AM, Mohammadpour N,
Abedin S, Atyabi F, Dinarvand R and Rafiee-
Tehrani M. Preparation and characterization of
insulin nanoparticles using chitosan and Arabic
gum with ionic gelation method. Nanomedicine.
(2010) 6: 58-63.
(20) Varshosaz J, Taymouri S, Jahanian-Najafabadi A
and Alizadeh A. Efavirenz oral delivery via lipid
nanocapsules: formulation, optimisation, and exvivo
gut permeation study. IET Nanobiotechnol.
(2018) 12: 795-806.
(21) Bnyan R, Khan I, Ehtezazi T, Saleem I, Gordon
S, O’Neill F and Roberts M. Formulation and
optimisation of novel transfersomes for sustained
release of local anaesthetic. J. Pharm. Pharmacol.
(2019) 71: 1508-19
(22) Moawad FA, Ali AA and Salem HF.
Nanotransfersomes-loaded thermosensitive in situ
gel as a rectal delivery system of tizanidine HCl:
preparation, in-vitro and in-vivo performance.
Drug Deliv. (2017) 24: 252-60
(23) El Zaafarany GM, Awad GA, Holayel SM and
Mortada ND. Role of nois activators and surface
charge in developing ultradeformable vesicles with
enhanced skin delivery. Int. J. Pharm. (2010) 397:
164-72.
(24) Tavakoli N, Taymouri S, Saeidi A and Akbari V.
Thermosensitive hydrogel containing sertaconazole
loaded nanostructured lipid carriers for potential
treatment of fungal keratitis. Pharm. Dev Technol.
(2019) 24: 891-901.
(25) Abdelwahed W, Degobert G, Stainmesse S and Fessi
H. Freeze-drying of nanoparticles: formulation,
process and storage considerations. Adv. Drug
Deliv. Rev. (2006) 58: 1688-713.
(26) Umerska A, Paluch KJ, Santos-Martinez MJ,
Corrigan OI, Medina C and Tajber L. Freeze drying
of polyelectrolyte complex nanoparticles: Effect
of nanoparticle composition and cryoprotectant
selection. Int. J. Pharm. (2018) 552: 27-38.
(27) Holzer M, Vogel V, Mäntele W, Schwartz D, Haase
W and Langer K. Physico-chemical characterisation
of PLGA nanoparticles after freeze-drying and
storage. Eur. J. Pharm. Biopharm. (2009) 72: 428-
37.
(28) Jangdey MS, Gupta A, Saraf S and Saraf S.
Development and optimization of apigenin-loaded
transfersomal system for skin cancer delivery: invitro
evaluation. Artif. Cells Nanomed. Biotechnol.
(2017) 45: 1452-62.
(29) Mahmood S, Taher M and Mandal UK.
Experimental design and optimization of raloxifene
hydrochloride loaded nanotransfersomes for
transdermal application. Int. J. Nanomedicine
(2014) 9: 4331-46.
(30) Jain AK, Jain A, Garg NK, Agarwal A, Jain A, Jain
SA, Tyagi RK, Jain RK, Agrawal H and Agrawal
GP. Adapalene loaded solid lipid nanoparticles gel:
an effective approach for acne treatment. Colloids
Surf. B: Biointerfaces (2014) 121: 222-9.
(31) Peng Q, Sun X, Gong T, Wu CY, Zhang T, Tan J
and Zhang ZR. Injectable and biodegradable
thermosensitive hydrogels loaded with PHBHHx
nanoparticles for the sustained and controlled
release of insulin. Acta Biomater. (2013) 9: 5063-9.
(32) Ali MF, Salem HF, Abdelmohsen HF and Attia
SK. Preparation and clinical evaluation of
nano-transferosomes for treatment of erectile
dysfunction. Drug Des. Devel. Ther. (2015) 9:
2431-47.
(33) Venkatesh MP, Kumar TP and Pai DR. Targeted
drug delivery of Methotrexate in situ gels for the
treatment of Rheumatoid Arthritis. Saudi Pharm J.
(2020) 28: 1548-57.
(34) Lei W, Yu C, Lin H, Zhou X. Development of
tacrolimus-loaded transfersomes for deeper skin
penetration enhancement and therapeutic effect
improvement in-vivo. Asian J. Pharm. Sci. (2013)
8: 336-45.
This article is available online at http://www.i